Please enable JavaScript to continue using this application.

Compare $AKBA vs $SION | Chartloom

Compare

$AKBA vs $SION

Akebia Therapeutics Inc · Sionna Therapeutics Inc

AKBA

Akebia Therapeutics Inc

SION

Sionna Therapeutics Inc

Compare $AKBA vs $SION

Comparing Akebia Therapeutics Inc and Sionna Therapeutics Inc

AKBAAkebia Therapeutics Inc

SIONSionna Therapeutics Inc

AKBAAkebia Therapeutics Inc

Market cap

$215M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.35x

Rev growth (TTM)

7.5%

YTD performance

-48.3%

52W performance

-71.9%

FCF yield

13.7%

SIONSionna Therapeutics Inc

Market cap

$221M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-87.5%

52W performance

-82.8%

FCF yield

-34.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AKBA

SION

Detailed metrics comparison

AKBA

Akebia Therapeutics Inc

SION

Sionna Therapeutics Inc

Market Cap

AKBA$215M

SION$221M

Enterprise Value

AKBA$252M

SION$158M

Price

AKBA$0.80

SION$4.90

P/E Ratio

AKBAN/A

SIONN/A

P/S Ratio

AKBA0.98x

SION0.00x

EV/Sales

AKBA1.15x

SION0.00x

EV/EBITDA

AKBA49.22x

SION0.00x

P/B Ratio

AKBA9.58x

SION0.84x

P/FCF Ratio

AKBA7.30x

SIONN/A

EV/FCF

AKBA8.54x

SION-2.07x

PEG Ratio

AKBAN/A

SIONN/A

Forward P/E (NTM)

AKBAN/A

SIONN/A

Forward P/S (NTM)

AKBA1.35x

SIONN/A

Revenue (TTM)

AKBA$219M

SION$0

Revenue Growth (YoY)

AKBA7.5%

SIONN/A

Forward Rev Growth

AKBA-33.0%

SION1297.1%

Gross Margin (TTM)

AKBA81.5%

SION0.0%

Operating Margin (TTM)

AKBA0.0%

SION0.0%

EBITDA Margin (TTM)

AKBA-1.9%

SION0.0%

Net Margin (TTM)

AKBA-13.5%

SION0.0%

FCF Margin (TTM)

AKBA13.4%

SIONN/A

Net Income (TTM)

AKBA$-30M

SION$-97M

FCF (TTM)

AKBA$29M

SION$-76M

EPS (TTM)

AKBA-$0.11

SION-$2.16

ROE (TTM)

AKBA-9374.0%

SION-3294.0%

ROA (TTM)

AKBA-817.0%

SION-3108.0%

ROIC (TTM)

AKBA-1321.0%

SION-3294.0%

Cash

AKBA$156M

SION$63M

Debt

AKBA$192M

SION$0

Net Cash/Debt

AKBA$-37M

SION$63M

Current Ratio (TTM)

AKBA1.43x

SION20.05x

Quick Ratio (TTM)

AKBA1.31x

SION19.57x

Debt/Equity (TTM)

AKBA7.69x

SION0.00x

Debt/Assets (TTM)

AKBA0.0%

SION0.0%

Interest Coverage (TTM)

AKBAN/A

SIONN/A

Net Debt/EBITDA (TTM)

AKBA0.00x

SION0.00x

Beta

AKBA0.20

SION1.44

52W Performance

AKBA-71.9%

SION-82.8%

YTD Performance

AKBA-48.3%

SION-87.5%

% from 52W High

AKBA-75.0%

SION-91.1%

% from 52W Low

AKBA0.0%

SION22.2%

Asset Turnover (TTM)

AKBA0.60x

SION0.00x

FCF Yield (TTM)

AKBA13.7%

SION-34.4%

Earnings Yield (TTM)

AKBA-13.8%

SION-44.0%

Dividend Yield (TTM)

AKBAN/A

SIONN/A

Rule of 40

AKBA21.0

SION0.0

EV/GP/RG

AKBAN/A

SIONN/A

Ticker research

View AKBA research View SION research

Metric	AKBA Akebia Therapeutics Inc	SION Sionna Therapeutics Inc
Market & Valuation
Market Cap	$215M	$221M
Enterprise Value	$252M	$158M
Price	$0.80	$4.90
P/E Ratio	N/A	N/A
P/S Ratio	0.98x	0.00x
EV/Sales	1.15x	0.00x
EV/EBITDA	49.22x	0.00x
P/B Ratio	9.58x	0.84x
P/FCF Ratio	7.30x	N/A
EV/FCF	8.54x	-2.07x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.35x	N/A
Revenue & Growth
Revenue (TTM)	$219M	$0
Revenue Growth (YoY)	7.5%	N/A
Forward Rev Growth	-33.0%	1297.1%
Profitability
Gross Margin (TTM)	81.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1.9%	0.0%
Net Margin (TTM)	-13.5%	0.0%
FCF Margin (TTM)	13.4%	N/A
Net Income (TTM)	$-30M	$-97M
FCF (TTM)	$29M	$-76M
EPS (TTM)	-$0.11	-$2.16
ROE (TTM)	-9374.0%	-3294.0%
ROA (TTM)	-817.0%	-3108.0%
ROIC (TTM)	-1321.0%	-3294.0%
Financial Health
Cash	$156M	$63M
Debt	$192M	$0
Net Cash/Debt	$-37M	$63M
Current Ratio (TTM)	1.43x	20.05x
Quick Ratio (TTM)	1.31x	19.57x
Debt/Equity (TTM)	7.69x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.20	1.44
52W Performance	-71.9%	-82.8%
YTD Performance	-48.3%	-87.5%
% from 52W High	-75.0%	-91.1%
% from 52W Low	0.0%	22.2%
Efficiency & Yields
Asset Turnover (TTM)	0.60x	0.00x
FCF Yield (TTM)	13.7%	-34.4%
Earnings Yield (TTM)	-13.8%	-44.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	21.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AKBA research	View SION research

Valuation

P/S Ratio

SION

0.00x

AKBA

0.98x

EV/FCF

SION

-2.07x

AKBA

8.54x

Growth & revenue

Revenue Growth TTM

AKBA

7.5%

Forward Revenue Growth

SION

1297.1%

AKBA

-33.0%

Profitability & performance

Gross Margin

AKBA

81.5%

SION

0.0%

ROE

SION

-3294.0%

AKBA

-9374.0%

FCF Yield %

AKBA

13.7%

SION

-34.4%

52-Week Performance

AKBA

-71.9%

SION

-82.8%

Detailed metrics comparison

AKBA

Akebia Therapeutics Inc

SION

Sionna Therapeutics Inc

Market Cap

AKBA$215M

SION$221M

Enterprise Value

AKBA$252M

SION$158M

Price

AKBA$0.80

SION$4.90

P/E Ratio

AKBAN/A

SIONN/A

P/S Ratio

AKBA0.98x

SION0.00x

EV/Sales

AKBA1.15x

SION0.00x

EV/EBITDA

AKBA49.22x

SION0.00x

P/B Ratio

AKBA9.58x

SION0.84x

P/FCF Ratio

AKBA7.30x

SIONN/A

EV/FCF

AKBA8.54x

SION-2.07x

PEG Ratio

AKBAN/A

SIONN/A

Forward P/E (NTM)

AKBAN/A

SIONN/A

Forward P/S (NTM)

AKBA1.35x

SIONN/A

Revenue (TTM)

AKBA$219M

SION$0

Revenue Growth (YoY)

AKBA7.5%

SIONN/A

Forward Rev Growth

AKBA-33.0%

SION1297.1%

Gross Margin (TTM)

AKBA81.5%

SION0.0%

Operating Margin (TTM)

AKBA0.0%

SION0.0%

EBITDA Margin (TTM)

AKBA-1.9%

SION0.0%

Net Margin (TTM)

AKBA-13.5%

SION0.0%

FCF Margin (TTM)

AKBA13.4%

SIONN/A

Net Income (TTM)

AKBA$-30M

SION$-97M

FCF (TTM)

AKBA$29M

SION$-76M

EPS (TTM)

AKBA-$0.11

SION-$2.16

ROE (TTM)

AKBA-9374.0%

SION-3294.0%

ROA (TTM)

AKBA-817.0%

SION-3108.0%

ROIC (TTM)

AKBA-1321.0%

SION-3294.0%

Cash

AKBA$156M

SION$63M

Debt

AKBA$192M

SION$0

Net Cash/Debt

AKBA$-37M

SION$63M

Current Ratio (TTM)

AKBA1.43x

SION20.05x

Quick Ratio (TTM)

AKBA1.31x

SION19.57x

Debt/Equity (TTM)

AKBA7.69x

SION0.00x

Debt/Assets (TTM)

AKBA0.0%

SION0.0%

Interest Coverage (TTM)

AKBAN/A

SIONN/A

Net Debt/EBITDA (TTM)

AKBA0.00x

SION0.00x

Beta

AKBA0.20

SION1.44

52W Performance

AKBA-71.9%

SION-82.8%

YTD Performance

AKBA-48.3%

SION-87.5%

% from 52W High

AKBA-75.0%

SION-91.1%

% from 52W Low

AKBA0.0%

SION22.2%

Asset Turnover (TTM)

AKBA0.60x

SION0.00x

FCF Yield (TTM)

AKBA13.7%

SION-34.4%

Earnings Yield (TTM)

AKBA-13.8%

SION-44.0%

Dividend Yield (TTM)

AKBAN/A

SIONN/A

Rule of 40

AKBA21.0

SION0.0

EV/GP/RG

AKBAN/A

SIONN/A

Ticker research

View AKBA research View SION research

Metric	AKBA Akebia Therapeutics Inc	SION Sionna Therapeutics Inc
Market & Valuation
Market Cap	$215M	$221M
Enterprise Value	$252M	$158M
Price	$0.80	$4.90
P/E Ratio	N/A	N/A
P/S Ratio	0.98x	0.00x
EV/Sales	1.15x	0.00x
EV/EBITDA	49.22x	0.00x
P/B Ratio	9.58x	0.84x
P/FCF Ratio	7.30x	N/A
EV/FCF	8.54x	-2.07x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.35x	N/A
Revenue & Growth
Revenue (TTM)	$219M	$0
Revenue Growth (YoY)	7.5%	N/A
Forward Rev Growth	-33.0%	1297.1%
Profitability
Gross Margin (TTM)	81.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1.9%	0.0%
Net Margin (TTM)	-13.5%	0.0%
FCF Margin (TTM)	13.4%	N/A
Net Income (TTM)	$-30M	$-97M
FCF (TTM)	$29M	$-76M
EPS (TTM)	-$0.11	-$2.16
ROE (TTM)	-9374.0%	-3294.0%
ROA (TTM)	-817.0%	-3108.0%
ROIC (TTM)	-1321.0%	-3294.0%
Financial Health
Cash	$156M	$63M
Debt	$192M	$0
Net Cash/Debt	$-37M	$63M
Current Ratio (TTM)	1.43x	20.05x
Quick Ratio (TTM)	1.31x	19.57x
Debt/Equity (TTM)	7.69x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.20	1.44
52W Performance	-71.9%	-82.8%
YTD Performance	-48.3%	-87.5%
% from 52W High	-75.0%	-91.1%
% from 52W Low	0.0%	22.2%
Efficiency & Yields
Asset Turnover (TTM)	0.60x	0.00x
FCF Yield (TTM)	13.7%	-34.4%
Earnings Yield (TTM)	-13.8%	-44.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	21.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AKBA research	View SION research